Mrs
Rachel
Fetches

Partner & Head of Law

London Office

Chemistry

Telephone. +44(0) 207 776 5111
Mobile. +44(0) 782 790 9139
Email. [email protected]

Experience

Rachel is an IP/Patent Litigation Partner and advises on contentious intellectual property matters for clients across a broad range of sectors including, life sciences, pharmaceuticals, healthcare, chemicals, food and beverage, aviation, media and telecommunications industries. She has extensive experience of litigating before the UK Patents Court, High Court and Court of Appeal. She has also regularly advised in relation to pan-European IP litigation strategy for both patents and trade marks. Rachel is currently leading HGF's UPC team.

Qualifications

Solicitor

England & Wales
Ireland
Other
Republic of Ireland


BSC

Cell Biotechnology (Spec)

MA

Health Care Ethics

POSTGRADUATE DIPLOMA OR CERTIFICATE

Intellectual Property Law

OTHER

PgDL/LPC College of Law

Recognition

MIP Stars Handbook 2016

“Rachel is an accomplished patent litigator with an excellent pedigree in life sciences” says a peer

IAM Patent 1000

“Rachel Fetches is the woman to go to. Her weighty workload includes substantial matters such as representing Accord Healthcare against Research Technologies a complex case that has involved expert testimony from US federal law and Texas state law experts”

Legal500, London: Intellectual Property - patents (contentious and non-contentious)

HGF Limited’s patent litigators have strength in the life sciences sector, as evidenced by Rachel Fetches’ representation of multinational generic pharmaceuticals companies in patent infringement defence and oppositions.

View recognition online

Publications

Prominence given to the preservation of the status quo

View publication online

Blockbuster blood thinning patent revoked

View publication online

IPBC Europe 2022

View publication online

UPC could open its doors in 2022

View publication online

A new dawn for SPCs

View publication online

UK Supreme Court invalidates Regeneron's transgenic mouse patents for lack of sufficiency

View publication online

SKY Trade Marks applied for to use purely as “Legal Weapon” are held to be invalid

View publication online

HGF wins Scottish “Firm of the Year” for Prosecution at the MIP Awards

View publication online

The end of the UPC as we know it?

View publication online

SkyKick ruling

View publication online

Clearing out the clutter – SkyKick may open up trade mark registers Across Europe

View publication online

The Vedanta Opposition: A healthy sign of a maturing industry

View publication online

Test for obviousness for dosage patents clarified by the Supreme Court

View publication online

Conferences: 2022

November 29th 2022

LSPN Europe 2022

Speaker

Event details

October 25th 2022

Webinar: Litigating in the Unified Patent Court

Speaker

Event details

October 6th 2022

UPC event in Ireland: Maintaining commercial relevance of your European IP strategy with the new Unified Patent Court system

Speaker

Event details

March 7th 2022

IQPC Global Exchange Europe 2022

Speaker

Event details

Conferences: 2021

March 2nd 2021

MIP International Patent Forum

Attended

Event details

February 9th 2021

HGF IP in Healthcare Virtual Conference

Speaker

Event details

January 14th 2021

HGF IP in Healthcare Virtual Conference 2021

Speaker

Event details

Conferences: 2020

November 2nd 2020

AIPPI Congress London

Attended

Event details

Conferences: 2019

November 26th 2019

IQPC Lifesciences in IP

Attended

Event details

November 26th 2019

IQPC Life Science IP 2019 - London

Attended

Event details

November 21st 2019

Life Sciences Patent Network

Attended

Event details

June 3rd 2019

2019 BIO International Convention - Philadelphia

Attended

Event details

March 19th 2019

HGF IP in Healthcare Conference

Speaker

Event details

March 14th 2019

IP in Healthcare Conference 2019 - London & Manchester

Speaker

Event details

Conferences: 2018

November 27th 2018

IQPC Life Sciences IP Conference

Speaker

Event details

Related News

EPO Board of Appeal decision indicates approach to Core AI Inventions

Potential obstacles to obtaining patent protection in Europe for an improvement in a general method for machine learning have been highlighted by a recent decision (T0702/20) from the EPO Board …

Read article

WIPR article - Rolex: is the trademark world its Oyster?

HGF Trade Mark Director Claire Jones comments in the WIPR article on ‘Rolex: is the trademark world it’s Oyster?’. The article written by Sarah Speight looks at how the luxury …

Read article

From Theoretical Proposals to Commercial Reality: The Rise of Innovation and Patent Filings in Quantum Computing

The possibility of quantum computing was first seriously proposed in the early 1980s and is widely regarded as having enormous potential to deliver a step change in the complexity of …

Read article
Event - 3rd February 2023

The European Patent Office are running an inspiring collaborative art competition for children

To celebrate the 50th anniversary of the signing of the European Patent Convention, The European Patent Office (EPO) is running a collaborative art competition for primary schools on the topic …

Event details
Event - 8th-9th February 2023

5th Annual Microbiome & Probiotic Conference 2023

The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …

Event details
Event - 17th January 2023

CIPA Webinar: Enhancing Diversity in the Patent Profession How Can I Help

CIPA hosted a webinar to discuss ‘Enhancing diversity in the patent profession.’ Date Tuesday 17 January, 2023 Time 12.30pm – 1.30pm (GMT) Equity, diversity and inclusion has been in the …

Event details

LiDAR: A Significant Support Technology at CES

When visiting CES’ one thing that struck me was the number of companies demonstrating LiDAR technology. LiDAR has been around since the 1960s and was originally developed for aerospace use, …

Read article

Parallel importation of pharmaceuticals – when is repackaging necessary?

The repackaging of pharmaceutical products by parallel importers is a long debated subject. The above question was reconsidered in a set of judgements by the CJEU in November last year …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.